Drug Improves Sight for Patients with Inherited Blindness

The drug idebenone improved the vision and perception of color in patients with Leber’s hereditary optic neuropathy, which leads to loss of sight in both eyes, according to a report in Brain.

Advertisement

 

The drug, which goes by the brand name Catena, improved vision for some severely affected patients, including those who were unable to read any letters on an eye chart.

 

Inherited from the mother, and mainly affecting men, LHON is caused by damage to the mitochondria in the eyes.

 

Read the Brain report on idebenone for patients with Leber’s.

 

Related Articles on Blindness:

Study: Too Much Oxygen in Eyes Linked to High Glaucoma Rates for Blacks

Dr. William Lahners Discusses Florida’s Center for Sight Involvement in Mission Cataract

Triamcinolone Injections May Slow Progression of Diabetic Retinopathy

 

 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.